WO1995032297B1 - Novel chromosome fragment and its use as a vector - Google Patents

Novel chromosome fragment and its use as a vector

Info

Publication number
WO1995032297B1
WO1995032297B1 PCT/GB1995/001195 GB9501195W WO9532297B1 WO 1995032297 B1 WO1995032297 B1 WO 1995032297B1 GB 9501195 W GB9501195 W GB 9501195W WO 9532297 B1 WO9532297 B1 WO 9532297B1
Authority
WO
WIPO (PCT)
Prior art keywords
chromosome
vector according
fragment
human
vector
Prior art date
Application number
PCT/GB1995/001195
Other languages
French (fr)
Other versions
WO1995032297A1 (en
Filing date
Publication date
Priority claimed from GB9410446A external-priority patent/GB9410446D0/en
Application filed filed Critical
Priority to AU25343/95A priority Critical patent/AU2534395A/en
Publication of WO1995032297A1 publication Critical patent/WO1995032297A1/en
Publication of WO1995032297B1 publication Critical patent/WO1995032297B1/en

Links

Abstract

The present invention relates to the field of molecular genetics and in particular to artificial chromosomes, to their preparation in particular using telomere-directed chromosome fragmentation techniques and to their use as DNA vectors, for instance for application in gene therapy and animal transgenesis. Vectors of the invention comprise a chromosome fragment which fragment is at least partly responsible for centromere function of the parent chromosome and is capable of replication and segregation during cell cycle, and which is of such a size that it can be resolved using gel electrophoresis. Suitable fragments are derived from the human Y chromosome.

Claims

39AMENDED CLAIMS[received by the International Bureau on 18 December 1995 (18.12.95); original claim 1 amended; remaining claims unchanged (1 page)]
1. A vector comprising a chromosome fragment other than a yeast chromosome fragment, which fragment comprises sequences which have centromeric activity, is capable of replication and segregation during cell cycle, and is of such a size that it can be resolved using gel electrophoresis.
2. A vector according to claim 1 which is derived from the human Y chromosome.
3. A vector according to claim 2 comprising a linear derivative of the human Y chromosome which includes at least some alphoid DNA.
4. A vector according to claim 2 or claim 3 which is derived solely from the short arm of the human Y chromosome.
5. A vector according to claims 2 or claim 3 which is derived solely from the long arm of the human Y chromosome.
6. A vector according to any one of the preceding claims which is less than 6Mb in size.
7. A vector according to claim 6 which is less than 3.5 megabase in size.
8. A process for obtaining a vector according to any one of the preceding claims which process comprises dissecting a chromosome in such a manner that a fragment retaining centromere function is retained.
PCT/GB1995/001195 1994-05-25 1995-05-25 Novel chromosome fragment and its use as a vector WO1995032297A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU25343/95A AU2534395A (en) 1994-05-25 1995-05-25 Novel chromosome fragment and its use as a vector

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9410446.0 1994-05-25
GB9410446A GB9410446D0 (en) 1994-05-25 1994-05-25 Novel chromosome fragment

Publications (2)

Publication Number Publication Date
WO1995032297A1 WO1995032297A1 (en) 1995-11-30
WO1995032297B1 true WO1995032297B1 (en) 1996-01-18

Family

ID=10755674

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1995/001195 WO1995032297A1 (en) 1994-05-25 1995-05-25 Novel chromosome fragment and its use as a vector

Country Status (4)

Country Link
AU (1) AU2534395A (en)
GB (1) GB9410446D0 (en)
WO (1) WO1995032297A1 (en)
ZA (1) ZA954300B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2042093C (en) * 1990-05-09 2002-12-24 Gyula Hadlaczky Cell line carrying an excess of mammalian centromeres
US5869294A (en) * 1995-06-07 1999-02-09 Case Western Reserve University Method for stably cloning large repeating DNA sequences
US6348353B1 (en) * 1995-06-07 2002-02-19 Case Western Reserve University Artificial mammalian chromosome
US6632976B1 (en) 1995-08-29 2003-10-14 Kirin Beer Kabushiki Kaisha Chimeric mice that are produced by microcell mediated chromosome transfer and that retain a human antibody gene
US6025155A (en) * 1996-04-10 2000-02-15 Chromos Molecular Systems, Inc. Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US6077697A (en) * 1996-04-10 2000-06-20 Chromos Molecular Systems, Inc. Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
CA2263823C (en) 1996-08-26 2010-11-23 Tsuneko Okazaki Mammalian artificial chromosomes
TWI255853B (en) 1998-08-21 2006-06-01 Kirin Brewery Method for modifying chromosomes
WO2002010375A1 (en) * 2000-07-17 2002-02-07 Jiahui Xia Human source gene leading sequence, gene vector and gene expression strategy
US7041870B2 (en) 2000-11-30 2006-05-09 Medarex, Inc. Transgenic transchromosomal rodents for making human antibodies
CN100448992C (en) 2001-05-11 2009-01-07 麒麟医药株式会社 Artificial human chromosome containing human antibody lambda light chain gene

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889806A (en) * 1987-04-15 1989-12-26 Washington University Large DNA cloning system based on yeast artificial chromosomes
WO1989009219A1 (en) * 1988-03-24 1989-10-05 The General Hospital Corporation Artificial chromosome vector
WO1995003400A1 (en) * 1993-07-23 1995-02-02 Johns Hopkins University School Of Medicine Recombinationally targeted cloning in yeast artificial chromosomes

Similar Documents

Publication Publication Date Title
CA2184345A1 (en) Coordinate in vivo gene expression
AU2790292A (en) Viral recombinant vectors for expression in muscle cells
NZ504185A (en) Expression of endogenous genes by non-homologous recombination of a vector construct with cellular DNA
CA2128589A1 (en) Selection marker gene free recombinant strains: a method for obtaining them and the use of these strains
WO1998045456A8 (en) 2-deoxyglucose-6-phosphate (2-dog-6-p) phosphatase dna sequences as selection markers in plants
WO1995032297B1 (en) Novel chromosome fragment and its use as a vector
EP0331939A3 (en) Method and compositions for conferring resistance to retroviral infection
HK1046694A1 (en) Expression and export of interferon-alpha proteins as fc fusion proteins
CA2200371A1 (en) Human npik gene
CA2294516A1 (en) Ikk-.beta. proteins, nucleic acids and methods
WO1998011243A3 (en) Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein
EP2283721A3 (en) Genetically engineered duckweed
WO1997003192A3 (en) Chromosome 1 gene and gene products related to alzheimer's disease
HOU et al. The unusual structures of the hot-regions flanking large-scale deletions in human mitochondrial DNA
AU682140B2 (en) Multidrug resistance gene
Sung et al. Renaturation of DNA catalysed by yeast DNA repair and recombination protein RAD1O
KR920701443A (en) Urate oxidase active protein, recombinant genes for this protein, expression vector, microorganisms and transformed cells
AU5587198A (en) Methods for preparing nucleotide integrases
WO2000049162A3 (en) Compositions and methods for non-targeted activation of endogenous genes
CA2199832A1 (en) Anti-sickling beta-globin protein, compositions and methods for treating sickle cell disease
WO1994000572A3 (en) Gene for ataxia-telangiectasia complementation group d (atdc)
US4224408A (en) Deoxyribonucleic acid synthesis using binding protein
US4331589A (en) Deoxyribonucleic acid synthesis using binding protein extracted from chick embryo fibroblasts
EP1631672B1 (en) Circular expression construct for gene therapeutic applications
WO2002072768A3 (en) ISOGENIC ss-CATENIN CELL LINES, AND METHODS OF MAKING AND USING SAME